1. Home
  2. ALRM vs DNLI Comparison

ALRM vs DNLI Comparison

Compare ALRM & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarm.com Holdings Inc.

ALRM

Alarm.com Holdings Inc.

N/A

Current Price

$66.73

Market Cap

3.3B

Sector

Technology

ML Signal

N/A

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$18.00

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALRM
DNLI
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
ALRM
DNLI
Price
$66.73
$18.00
Analyst Decision
Buy
Strong Buy
Analyst Count
6
21
Target Price
★ $73.00
$35.82
AVG Volume (30 Days)
478.5K
★ 1.4M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 7.42
N/A
EPS
★ 1.61
N/A
Revenue
★ $1,011,187,000.00
N/A
Revenue This Year
$9.42
N/A
Revenue Next Year
$6.86
$202.76
P/E Ratio
$41.29
★ N/A
Revenue Growth
★ 7.59
N/A
52 Week Low
$41.49
$15.34
52 Week High
$69.40
$27.30

Technical Indicators

Market Signals
Indicator
ALRM
DNLI
Relative Strength Index (RSI) 65.64 38.77
Support Level $63.66 N/A
Resistance Level $69.40 $21.45
Average True Range (ATR) 1.98 0.94
MACD -0.27 -0.14
Stochastic Oscillator 53.44 16.53

Price Performance

Historical Comparison
ALRM
DNLI

About ALRM Alarm.com Holdings Inc.

Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected device.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: